What is First Choice Laboratory?
First Choice Laboratory operates as a high-complexity diagnostics provider, specializing in a comprehensive suite of services that includes genetic screening, toxicology, and infectious disease testing. By integrating advanced laboratory workflows with precision medicine initiatives, the company enables healthcare providers to transition toward more personalized patient care models. Their national network of laboratories is engineered for high-throughput efficiency, ensuring that clinical decision-making is supported by rapid, accurate, and actionable data. As the demand for sophisticated diagnostic solutions continues to rise, First Choice Laboratory remains at the forefront of the industry, bridging the gap between complex molecular analysis and routine clinical practice.
How much funding has First Choice Laboratory raised?
First Choice Laboratory has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in First Choice Laboratory
PPP
Public-Private Partnership
What's next for First Choice Laboratory?
With this late-stage funding secured, First Choice Laboratory is poised to scale its diagnostic capabilities and expand its market reach. The strategic deployment of these funds will likely focus on upgrading laboratory automation, enhancing data analytics platforms, and potentially pursuing inorganic growth opportunities to consolidate its market share. As the company matures, the focus will shift toward optimizing operational margins and deepening its integration into large-scale healthcare networks. This capital infusion provides the necessary runway to navigate the evolving regulatory landscape while maintaining the high standards of accuracy and turnaround time that define their service offering. Investors and industry stakeholders will be watching closely as the firm leverages this liquidity to drive long-term value in the precision medicine space.
See full First Choice Laboratory company page
